BriaCell Therapeutics (NASDAQ:BCTX) Price Target Raised to $32.00
BriaCell Therapeutics (NASDAQ:BCTX – Get Free Report) had its price target lifted by investment analysts at HC Wainwright from $15.00 to $32.00 in a research note issued to investors on ...
Biomednewsbreaks - Briacell Therapeutics Corp. (NASDAQ: BCTX) (TSX: BCT) Announces Pricing ...
BriaCell (NASDAQ: BCTX, BCTXW) (TSX: BCT) , a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, has ...